v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating activities:        
Net loss $ (4,389) $ (10,780) $ (12,858) $ (23,767)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization     481 556
Amortization of identified intangible assets 800 800 1,601 1,875
Amortization of deferred loan origination costs     89 54
Amortization of deferred sales commissions 900 800 1,759 1,507
Non-cash lease expense     666 931
Stock-based compensation expense     5,891 5,902
Credit loss expense 494 369 907 402
Loss on disposition or impairment of asset     509 0
Deferred income tax benefit     (18) (91)
Net realized loss on sale of marketable securities 24 33 75 42
Amortization of premium paid on marketable securities     181 246
Change in the fair value of the warrant liability (116) (92) (183) (484)
Changes in assets and liabilities        
Accounts receivable     (889) 1,203
Other assets     431 2,340
Deferred sales commissions     (2,507) (1,919)
Accounts payable     (156) (409)
Accrued expenses     (1,344) (3,647)
Deferred revenue     259 (169)
Operating lease liabilities     (795) (990)
Net cash used in operating activities     (5,901) (16,418)
Investing activities:        
Purchases of property and equipment     (48) (772)
Purchases of marketable securities     (12,965) (5,413)
Proceeds from sale of marketable securities 2,493 1,936 10,097 3,451
Proceeds from maturities and principal paydowns of marketable securities     7,643 2,652
Net cash provided by (used in) investing activities     4,727 (82)
Financing activities:        
Repayments on loan payable     (421) (280)
Proceeds from drawdown on line of credit     320 0
Repayments of drawdown on line of credit     (320) 0
Debt issuance costs     (299) 0
Repayments on finance lease obligations     (11) (13)
Payments of employees’ withholding taxes on net share settlement of stock-based awards     (1,133) (317)
Principal payments under the structured payable arrangement     (441) 0
Net transfer from LiveVox TopCo     237 0
Net cash used in financing activities     (2,068) (610)
Effect of foreign currency translation     171 (234)
Net decrease in cash, cash equivalents and restricted cash     (3,071) (17,344)
Cash, cash equivalents, and restricted cash beginning of period     20,742 47,317
Cash, cash equivalents, and restricted cash end of period 17,671 29,973 17,671 29,973
Supplemental disclosure of cash flow information:        
Interest paid     2,696 1,626
Income taxes paid     899 247
Supplemental schedule of non-cash investing activities:        
Net unrealized loss (gain) on marketable securities     (586) 1,176
Additional right-of-use assets     0 617
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents:        
Cash and cash equivalents 17,671 29,873 17,671 29,873
Restricted cash, current 0 100 0 100
Total cash, cash equivalents and restricted cash $ 17,671 $ 29,973 $ 17,671 $ 29,973

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL